Exclusion Criteria
Presence of circulating blasts or current extra-medullary involvement by ALL
boolean
History of relevant CNS pathology or current CNS pathology
boolean
Prior allogeneic HSCT
boolean
Eligibility for treatment with TKIs
boolean
Systemic cancer chemotherapy within 2 weeks prior to study treatment
boolean
Therapy with monoclonal antibodies (rituximab, alemtuzumab) within 4 weeks prior to study treatment
boolean
Previous treatment with blinatumomab
boolean